Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
about
The evolution of vertebrate opioid receptorsMultigenerational and transgenerational inheritance of drug exposure: The effects of alcohol, opiates, cocaine, marijuana, and nicotineGenome-Wide Association of Heroin Dependence in Han ChineseDrug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.Pharmacotherapy of addictions.Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1)OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques.The genetics of addiction-a translational perspectiveAssociation of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addictionStrain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration.Extreme marginalization: addiction and other mental health disorders, stigma, and imprisonmentThe genetics of the opioid system and specific drug addictionsOpioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.Role of a functional human gene polymorphism in stress responsivity and addictionsOverview and historical perspective of four papers presented on research related to the endogenous opioid systemMu-opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic-pituitary-adrenal axis adrenocorticotropic hormone stress response to metyraponeMu opioids and their receptors: evolution of a concept.Opioid receptors: from binding sites to visible molecules in vivo.Functional characterization of human variants of the mu-opioid receptor geneGenotype patterns that contribute to increased risk for or protection from developing heroin addiction.Neurocognitive and neuroinflammatory correlates of PDYN and OPRK1 mRNA expression in the anterior cingulate in postmortem brain of HIV-infected subjects.Insight into pain-inducing and -related gene expression: a challenge for development of novel targeted therapeutic approaches.A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation.OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence.The epigenetic regulation of the opioid system: new individualized prompt prevention and treatment strategies.The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.Morphine-induced internalization of the L83I mutant of the rat μ-opioid receptorOn the role of genetic testing for personalized drug overdose management.Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells.Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse.Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty.Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden.Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers.
P2860
Q24627645-3E4F248C-07B0-4756-93D3-963E3F6B7358Q27022465-71329F40-D990-4B3F-A510-3FCD30918D4BQ28554877-B2A2FCC8-6D8D-4C8A-B235-E2B455E993A7Q33643136-DFF738CB-4BE9-43C8-AC56-4C68C143AC5FQ33921223-7A5CA28C-5DF6-40B0-B639-6AE31EC57AB2Q34033200-F8C6E150-F976-407F-9B1E-2497ED20A55CQ34810395-36AD85B9-1934-400F-A3A8-80E7E4A5BE5EQ34939590-6E4BF271-7CE2-4F3F-A930-2860B0755A48Q35091270-8FA2756E-F0C2-4FF0-ABFF-3E7AA7D834EFQ36135947-4370B3C1-FD9A-48BC-90E3-8BA473A04D8FQ36762016-1043AA41-6E9E-473D-B324-A2BA1412656AQ36972785-CD7320B2-6252-46AD-A8FA-BD1905899403Q37027238-670341AE-F185-40D6-A9C5-1A8B5DED229BQ37040492-FAEDC2E2-E517-4D6D-827D-99DE6A48B183Q37065797-8FA8FE3F-DF39-4A02-BDCD-FCD94E95F501Q37103624-52FD5FC7-5748-48AB-848B-A3CCC7115CD2Q37146219-EB57753D-E4CF-4971-BE78-A7526EFA7268Q37213133-4A1E0805-1A59-483D-889D-C84903372951Q37236111-0709DF20-2764-44AB-B7C2-5FC180F98F52Q37249017-E8E2981E-C69E-4425-8FB9-83B13D7ED2E7Q37249905-1EC5C7F2-B758-441B-A66D-12FAA7CCCA65Q37260386-9D274E42-5B18-45E1-BC1F-BFF1DDD47DFFQ37496856-D548EB53-5285-4FA5-946A-3A75920BE444Q37673263-F953B0AA-071F-4574-910F-0D50F64BB3B5Q38016946-5DC9B007-51F7-4263-8E8D-854390FEB5C6Q38104745-AD97986E-93BE-4406-A325-64FB88DB352DQ38477907-F9AE25DD-64D8-4AF8-9737-8FC2DF4C5317Q38479752-79B4456D-0DFA-4180-8879-E7F828130203Q40079119-F6E0A6B9-33BA-4EB8-8D64-AE00F25EACD4Q40392922-C29A45EA-0955-4BDC-BBFC-76C228CE1E60Q40566502-B7B0820E-7150-46A4-AAA0-DCD9F12EB6EAQ41823097-6D86589F-87AD-43CE-A73F-6F750B776633Q42604309-7DF7F40C-77B7-48E1-B3CC-5BD5892ECAA2Q43722386-0DA200F4-F5C2-4E37-9E69-A1A4BA448FC5Q43981246-F3DBF761-8457-495F-9F83-D0272E69396AQ44331545-D1720D09-F7B2-42DF-90C4-B6E69734A0C2Q44344913-A8CAF484-5F06-41BC-9956-E84EDEC7BC7EQ44347117-4FC71C7D-88F0-44C9-AF7F-F2905AD983E6Q44347200-E7C2D44E-40D7-4BC2-A0B4-6FD10BFF8478Q44351630-62F4FE4A-BD60-4348-A22C-8143BD65246E
P2860
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@ast
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@en
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@nl
type
label
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@ast
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@en
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@nl
prefLabel
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@ast
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@en
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@nl
P2093
P1476
Opioid receptor and peptide gene polymorphisms: potential implications for addictions.
@en
P2093
P304
P356
10.1016/S0014-2999(00)00819-0
P407
P577
2000-12-01T00:00:00Z